Roosevelt Investment Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $4.67M | Buy |
106,821
+4,186
| +4% | +$203K | 0.34% | 57 |
|
|
2022
Q2 | $5.38M | Sell |
102,635
-854
| -0.8% | -$43.5K | 0.39% | 54 |
|
|
2022
Q1 | $5.36M | Buy |
103,489
+597
| +0.6% | +$31K | 0.32% | 55 |
|
|
2021
Q4 | $6.08M | Buy |
102,892
+7,998
| +8% | +$396K | 0.34% | 52 |
|
|
2021
Q3 | $4.08M | Buy |
94,894
+2,252
| +2% | +$99.8K | 0.25% | 60 |
|
|
2021
Q2 | $3.63M | Buy |
92,642
+1,518
| +2% | +$59K | 0.22% | 62 |
|
|
2021
Q1 | $3.3M | Buy |
91,124
+9,625
| +12% | +$342K | 0.22% | 64 |
|
|
2020
Q4 | $3M | Sell |
81,499
-237,693
| -74% | -$8.72M | 0.21% | 62 |
|
|
2020
Q3 | $11.1M | Buy |
319,192
+65,612
| +26% | +$2.3M | 0.9% | 42 |
|
|
2020
Q2 | $7.87M | Sell |
253,580
-144,721
| -36% | -$4.92M | 0.78% | 44 |
|
|
2020
Q1 | $12.3M | Sell |
398,301
-1,786
| -0.4% | -$60.9K | 1.41% | 30 |
|
|
2019
Q4 | $14.9M | Buy |
400,087
+8,588
| +2% | +$306K | 1.53% | 32 |
|
|
2019
Q3 | $13.3M | Buy |
391,499
+11,435
| +3% | +$416K | 1.52% | 34 |
|
|
2019
Q2 | $15.6M | Buy |
380,064
+666
| +0.2% | +$26.4K | 1.83% | 24 |
|
|
2019
Q1 | $15.3M | Sell |
379,398
-168,684
| -31% | -$6.76M | 1.9% | 25 |
|
|
2018
Q4 | $22.7M | Sell |
548,082
-69,833
| -11% | -$2.9M | 2.48% | 9 |
|
|
2018
Q3 | $25.8M | Buy |
617,915
+48,641
| +9% | +$1.87M | 2.35% | 9 |
|
|
2018
Q2 | $19.6M | Sell |
569,274
-4,406
| -0.8% | -$151K | 1.83% | 18 |
|
|
2018
Q1 | $19.3M | Sell |
573,680
-5,232
| -0.9% | -$180K | 1.82% | 17 |
|
|
2017
Q4 | $19.9M | Buy |
578,912
+71,843
| +14% | +$2.45M | 1.82% | 17 |
|
|
2017
Q3 | $17.2M | Buy |
507,069
+73,120
| +17% | +$2.35M | 1.58% | 18 |
|
|
2017
Q2 | $13.8M | Buy |
433,949
+381,176
| +722% | +$12M | 1.27% | 31 |
|
|
2017
Q1 | $1.71M | Sell |
52,773
-134,163
| -72% | -$4.23M | 0.16% | 117 |
|
|
2016
Q4 | $5.76M | Sell |
186,936
-1,004,569
| -84% | -$30.7M | 0.51% | 67 |
|
|
2016
Q3 | $38.3M | Sell |
1,191,505
-63,900
| -5% | -$2.14M | 3.03% | 1 |
|
|
2016
Q2 | $41.9M | Buy |
1,255,405
+143,329
| +13% | +$4.57M | 3.25% | 2 |
|
|
2016
Q1 | $31.3M | Sell |
1,112,076
-156,778
| -12% | -$4.48M | 2.78% | 7 |
|
|
2015
Q4 | $38.9M | Sell |
1,268,854
-401,946
| -24% | -$12.6M | 2.55% | 6 |
|
|
2015
Q3 | $49.8M | Sell |
1,670,800
-10,797
| -0.6% | -$346K | 3.23% | 4 |
|
|
2015
Q2 | $53.5M | Buy |
1,681,597
+209,998
| +14% | +$6.84M | 3.16% | 3 |
|
|
2015
Q1 | $48.6M | Sell |
1,471,599
-119,887
| -8% | -$3.81M | 2.65% | 7 |
|
|
2014
Q4 | $47M | Buy |
1,591,486
+120,607
| +8% | +$3.46M | 2.63% | 9 |
|
|
2014
Q3 | $41.3M | Sell |
1,470,879
-956,827
| -39% | -$26.9M | 2.2% | 16 |
|
|
2014
Q2 | $68.4M | Buy |
2,427,706
+233,328
| +11% | +$6.65M | 2.91% | 10 |
|
|
2014
Q1 | $66.9M | Sell |
2,194,378
-59,017
| -3% | -$1.76M | 3.1% | 7 |
|
|
2013
Q4 | $65.5M | Sell |
2,253,395
-157,646
| -7% | -$4.59M | 2.96% | 8 |
|
|
2013
Q3 | $65.7M | Sell |
2,411,041
-123,176
| -5% | -$3.35M | 2.92% | 6 |
|
|
2013
Q2 | $67.3M | Buy |
+2,534,217
| New | +$70M | 3.02% | 5 |
|
Other funds holding PFE
Roosevelt Investment Group's PFE Position: Q3 2022 in Review
Roosevelt Investment Group increased its Pfizer (PFE) stake by 4.1% in Q3 2022, buying an estimated $203K and bringing the position to 106,821 shares worth $4.67M. The position accounts for 0.34% of the portfolio, ranked #57.
Roosevelt Investment Group first reported a position in PFE in Q2 2013 and has held it in 38 quarters since. The position peaked at $68.4M in Q2 2014. 3,085 funds tracked by Wall St. Rank hold PFE as of Q3 2022.
- Roosevelt Investment Group held 106,821 shares of Pfizer worth $4.67M as of Q3 2022.
- Roosevelt Investment Group bought 4,186 Pfizer shares in Q3 2022, an estimated $203K.
- Pfizer made up 0.34% of Roosevelt Investment Group's portfolio in Q3 2022, its #57 holding.
- Roosevelt Investment Group first reported a position in Pfizer in Q2 2013 and has held it in 38 quarters since.
- Roosevelt Investment Group's Pfizer position peaked at $68.4M in Q2 2014.
- 3,085 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.
Based on Roosevelt Investment Group's 13F filing for Q3 2022, filed 19 Oct 2022.